Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution

Cites (623)

Items 601–609 of 609

1. A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in platinum-resistant ovarian cancer
   Garcia, Agustin A., Hays, John L., Cote, Gregory Michael, Becerra, Carlos, Langleben, Adrian, Lau, Susie K, Roman, Lynda D., McCormick, Colleen Catherine, Richards, Donald A., Braiteh, Fadi S. et al. · 2016 · Journal of Clinical Oncology
2. Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR)
   Monia Cecati, Davide Sartini, Valentina Pozzi · 2012 · The Journal of Maternal-Fetal & Neonatal Medicine
3. Untitled work
   Jatoi · 2013 · 10.1097/spc.0000000000000014
4. Filgotinib for Crohn's disease—expanding treatment options
   Ashwin N. Ananthakrishnan · 2016 · The Lancet
5. Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant
   Michael Thomas Byrne, Bipin N. Savani, Michael Robert Savona · 2018 · Therapeutic Advances in Hematology
6. STAT3 Nuclear Egress Requires Exportin 7 via Engaging Lysine Acetylation
   Andreas Herrmann Hua Yu · 2014 · MOJ Cell Science & Report
7. Inhibition of Interleukin-12 and/or -23 for the Treatment of Inflammatory Bowel Disease.
   E S Bruce · 2016 · PubMed
8. Correction: Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species†
   Hengjie Yuan, Katie Houck, Ye Tian et al. · 2016 · PLoS ONE
9. STAT3 regulates endothelial permeability downstream of the pro‐inflammatory cytokines IL6 and TNF‐α
   Hiba Alsaffar, Nina Martino, Peter A. Vincent · 2016 · The FASEB Journal